Pictet Asset Management (Switzerland)’s Legend Biotech LEGN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.5M	Buy	65,146 +4,206	+7%	+$275K	0.01%	790
2023 Q1	$2.94M	Buy	60,940 +6,458	+12%	+$316K	﹤0.01%	875
2022 Q4	$2.72M	Buy	54,482 +5,963	+12%	+$289K	﹤0.01%	877
2022 Q3	$1.98M	Buy	48,519 +1,038	+2%	+$48.7K	﹤0.01%	930
2022 Q2	$2.61M	Sell	47,481 -2,057	-4%	-$86.9K	﹤0.01%	897
2022 Q1	$1.8M	Buy	49,538 +4,194	+9%	+$166K	﹤0.01%	977
2021 Q4	$2.11M	Buy	+45,344	New	+$2.3M	﹤0.01%	994

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s LEGN Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Legend Biotech (LEGN) stake by 6.9% in Q2 2023, buying an estimated $275K and bringing the position to 65,146 shares worth $4.5M. The position accounts for 0.01% of the portfolio, ranked #790.

Pictet Asset Management (Switzerland) first reported a position in LEGN in Q4 2021 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold LEGN as of Q2 2023.

Pictet Asset Management (Switzerland) held 65,146 shares of Legend Biotech worth $4.5M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 4,206 Legend Biotech shares in Q2 2023, an estimated $275K.
Legend Biotech made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #790 holding.
Pictet Asset Management (Switzerland) first reported a position in Legend Biotech in Q4 2021 and has held it in 7 quarters since.
194 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.